Significant Concentrations |
3 Months Ended |
|---|---|
Mar. 31, 2023 | |
| Risks and Uncertainties [Abstract] | |
| Significant Concentrations | Significant Concentrations One customer accounted for approximately 19% and 22% of revenue for the three months ended March 31, 2023 and 2022, respectively. No other customers represented more than 10% of revenue for the three months ended March 31, 2023 and 2022.
No vendor accounted for more than 10% of purchases for the three months ended March 31, 2023. One vendor accounted for 63% of purchases for the three months ended March 31, 2022.
As of March 31, 2023, two customers accounted for approximately 30% and 18% of accounts receivable. As of December 31, 2022, two customers accounted for approximately 17% and 16% of accounts receivable. No other customers represented more than 10% of outstanding accounts receivable as of March 31, 2023 and December 31, 2022.
As of March 31, 2023, one vendor accounted for approximately 10% of accounts payable. As of December 31, 2022, one vendor accounted for approximately 10% of accounts payable. No other vendors represented more than 10% of outstanding accounts payable balance as of March 31, 2023 and December 31, 2022.
|
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|